ICOS: A New Costimulatory Ligand/Receptor Pair and Its Role in T-Cell Activion

Publisher： Karger

E-ISSN： 2296-5262|27|1|91-95

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.27, Iss.1, 2004-03, pp. : 91-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ICOS is required for the generation of both central and effector CD4+ memory T‐cell populations following acute bacterial infection

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 6, 2015-06 ,pp. : 1706-1715

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice

By Dziennis Suzan  

Metabolic Brain Disease, Vol. 26, Iss. 2, 2011-06 ,pp. : 123-133

Springer Publishing Company

Access to resources Recommend Favorite

Comparative analysis of murine T‐cell receptor repertoires

By  

IMMUNOLOGY, Vol. 153, Iss. 2, 2018-02 ,pp. : 133-144

John Wiley & Sons Inc

Access to resources Recommend Favorite

T-Cell Receptor-Mediated Cross-Allergenicity

By  

International Archives of Allergy and Immunology, Vol. 135, Iss. 4, 2004-12 ,pp. : 296-305

Karger

Access to resources Recommend Favorite

CD28/CTLA‐4/B7 costimulatory pathway blockade affects regulatory T‐cell function in autoimmunity

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 6, 2015-06 ,pp. : 1832-1841

John Wiley & Sons Inc

Access to resources Recommend Favorite